Yaohua Hu

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.

The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.

Journal: International journal of biological sciences

Published: January 27, 2026

Targeting MAO offers a novel immunotherapeutic strategy for prostate cancer by modulating the "tumor-stroma-immune" interaction network.

Targeting MAO offers a novel immunotherapeutic strategy for prostate cancer by modulating the "tumor-stroma-immune" interaction network.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 30, 2025

GRIN3A defines an immunosuppressive niche in advanced prostate cancer.

GRIN3A defines an immunosuppressive niche in advanced prostate cancer.

Journal: Medical oncology (Northwood, London, England)

Published: September 09, 2025

Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.

Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.

Journal: Journal for immunotherapy of cancer

Published: March 12, 2025

FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation.

FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation.

Journal: Cancer gene therapy

Published: October 30, 2024

JARID1D-dependent androgen receptor and JunD signaling activation of osteoclast differentiation inhibits prostate cancer bone metastasis through demethylating H3K4.

JARID1D-dependent androgen receptor and JunD signaling activation of osteoclast differentiation inhibits prostate cancer bone metastasis through demethylating H3K4.

Journal: Theranostics

Published: September 24, 2024

Curcumin blunts epithelial-mesenchymal transition to alleviate invasion and metastasis of prostate cancer through the JARID1D demethylation.

Curcumin blunts epithelial-mesenchymal transition to alleviate invasion and metastasis of prostate cancer through the JARID1D demethylation.

Journal: Cancer cell international

Published: June 18, 2024

Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.

Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.

Journal: International journal of biological macromolecules

Published: August 01, 2023

Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer.

Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer.

Journal: Biochemical and biophysical research communications

Published: March 17, 2022

Building kinetic models for determining vitamin C content in fresh jujube and predicting its shelf life based on near-infrared spectroscopy.

Building kinetic models for determining vitamin C content in fresh jujube and predicting its shelf life based on near-infrared spectroscopy.

Journal: Sensors (Basel, Switzerland)

Published: September 04, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026